Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid vs Denosumab in postmenopausal osteoporosis
IRCT20251201068176N1Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Dec 2025
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of zoledronic acid and denosumab in osteoporosis (2 arms), sponsored by Islamic Azad University. Started Dec 2025; status: completed.
02
Drugs
zoledronic aciddenosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on IRCT20251201068176N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251201068176N1.